30 years of experience
in life sciences investing
107 companies,
68 as startup ventures
$1.6 billion in funds
- December 20, 2017
- Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
- November 15, 2017
- Leap Therapeutics Announces $18 Million Private Placement Offering
- November 13, 2017
- Apellis Pharmaceuticals Announces Closing of its Initial Public Offering
- October 18, 2017
- Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic
- August 10, 2017
- Bioreclamationivt Acquires Biospecimen and Research Services Provider Asterand Bioscience
- August 4, 2017
- Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin, Its Proprietary Therapy In Late-Stage Development For Treatment Of Newborns At Risk For Developing Severe Jaundice